About one third of cancers detected by PSA screening at age 70, and more than half at age 80, are unlikely to become clinically meaningful within 15 years.

Men diagnosed at screening aged 50 years projected to have 16 percent chance that cancer would not have been detected within 15 years.

PHAROS, a real-world multi-country European study on patients with high-risk localised and locally advanced prostate cancer receiving radical treatment. This is an ASCO Meeting Abstract from the 2024 ...

PSA stands for prostate-specific antigen, a substance naturally produced in prostate tissue. A small amount of PSA regularly sneaks into the bloodstream, and low blood concentration is considered ...

Over the past decade, millions of men without symptoms of prostate cancer have voluntarily undergone a prostate-specific ...

This is a large-scale, population-based, observational study of two screening strategies: annual PSA screening and no screening. We used data from 537,599 US Medicare (2001-2008) beneficiaries age ...